Clinical Trials

13 enrolled

Suicide Prevention, Multiple Endocrine Neoplasia Type 1, Suicidal Ideation

NCT05461430 2026-04-13

TraveraRTGx

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

72 enrolled

Anus Neoplasms, Appendiceal Neoplasms, Ascites, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Small Cell, Carcinoma, Pancreatic Ductal, Gastrointestinal Stromal Tumors

NCT07247526 2026-04-09

Effect of Foot Bath on Anxiety and Physiological Parameters

100 enrolled

Anxiety Disorders, Pituitary Neoplasms

NCT05631795 2026-04-07

ALPINIST

Phase 4 Completed

40 enrolled

Multiple Endocrine Neoplasia Type 1

NCT04069299 2026-03-31

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

30 enrolled

Carcinoma, Neuroendocrine

NCT06826170 2026-03-30

HYPOADENO

25 enrolled

Pituitary Neoplasms

NCT00001452 2026-03-27

Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex

1,387 enrolled

Cushing Syndrome, Peutz-Jeghers Syndrome, Pituitary Neoplasms, Carney Complex

NCT00005927 2026-03-24

Study of Adrenal Gland Tumors

690 enrolled

Adrenal Gland Neoplasms, Cushing Syndrome

NCT04074642 2026-03-24

FIRST

21 enrolled

Pituitary Neoplasms

NCT03244956 2026-03-23

MERAIODE

40 enrolled

Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation

NCT05361668 2026-03-19

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

36 enrolled 19 charts

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT02402920 2026-03-10

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Phase 1 Completed

83 enrolled 13 charts

Neuroendocrine Tumors

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

20 enrolled

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT07412158 2026-02-17

Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)

500 enrolled

Paraganglioma, Pheochromocytoma

NCT04365023 2026-02-13

TNE-bien-DIF

168 enrolled

Neuroendocrine Tumors

NCT01022515 2026-02-06

PHEO

60 enrolled

Essential Hypertension, Hypertension, Paraganglioma, Pheochromocytoma

NCT07391514 2026-02-06

Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma

131 enrolled

Thyroid Cancer, Papillary

NCT06235814 2026-02-05

MAPS

2 enrolled

Thyroid Cancer, Papillary

NCT02826928 2026-01-21

Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors

116 enrolled

Carcinoid Tumor

NCT04505553 2026-01-21

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

EndocrineGastrointestinalNET

78 enrolled 14 charts

Gastro-enteropancreatic neuroendocrine tumor, Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT07340437 2026-01-15

Clinical Study of 18F-Exendin-4 in Insulinoma

20 enrolled

Insulinoma

NCT07342686 2026-01-15

Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma

500 enrolled

Craniopharyngioma, Dwarfism, Pituitary

NCT04362436 2026-01-14

ArTisaN

24 enrolled

Neuroendocrine Tumors

NCT07339241 2026-01-14

Abdominal Circumference as a Predictor of Operative Time in Retroperitoneal Adrenalectomy for Pheochromocytoma

159 enrolled

Pheochromocytoma

NCT02324647 2026-01-07

SERENDIPITY

807 enrolled

Adrenal incidentaloma, Adrenocortical Carcinoma

NCT07317713 2026-01-05

A Two-decade Mortality Risk Analysis of Gastrointestinal Carcinoid Neoplasms: an Updated SEER-based Study 2000-2022

93,481 enrolled

Carcinoid Tumor

NCT07317726 2026-01-05

Recent Trends in Stage Migration of Gastrointestnial Carcinoid Tumors Over Two Decades: a Retrospective SEER-based Analysis 2000-2022

93,481 enrolled

Carcinoid Tumor

NCT03290079 2025-12-22

Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors

20 enrolled 12 charts

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05844332 2025-12-22

LUTATHERA Injection General Use Result Survey

347 enrolled

Somatostatin Receptor-positive Neuroendocrine Tumor

NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

15 enrolled

Neuroblastoma, Pheochromocytoma

NCT07291752 2025-12-18

The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022

93,481 enrolled

Carcinoid Tumor, Neoplasms, Neoplasms, Second Primary

NCT05745363 2025-12-16

Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer

Phase 1/2 Completed

33 enrolled

Differentiated Thyroid Cancer

NCT05280379 2025-12-09

Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

EndocrineGastrointestinalHead & Neck

33 enrolled

Thyroid Cancer, Papillary, Colonic Neoplasms

NCT03217097 2025-11-21

MGMT-NET

116 enrolled

Neuroendocrine Tumors

NCT00668291 2025-11-20

EVACARNEY

133 enrolled

Pigmented Nodular Adrenocortical Disease, Primary, 1, Carney Complex

NCT07229859 2025-11-17

Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening

332 enrolled

Differentiated Thyroid Cancer (DTC)

NCT03872401 2025-11-10

VESALIUS-CV

Phase 3 Completed

12,301 enrolled

Coronary Disease, Multiple Endocrine Neoplasia Type 1

NCT03455075 2025-10-30

Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

92 enrolled

EndocrineGenitourinaryNET

Multiple Endocrine Neoplasia Type 1

NCT03910660 2025-10-20

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

Phase 1/2 Completed

98 enrolled

Prostatic Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT05307328 2025-10-08

RESCUE

26 enrolled

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT00410761 2025-09-24

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

Phase 3 Completed

331 enrolled 15 charts

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

NCT06358001 2025-09-22

EchoTip AcuCore Post-Market Clinical Study

EndocrineGastrointestinalLymphoidNET

183 enrolled

Autoimmune Pancreatitis, Adenocarcinoma, Carcinoma, Hepatocellular, Lymphoma, Neoplasm Metastasis, Cholangiocarcinoma, Neuroendocrine Tumors, Pancreatitis, Chronic

NCT07180641 2025-09-18

REMENOCOR

EndocrineGastrointestinal

1,039 enrolled

Non-colorectal Liver Metastasis

NCT05077384 2025-09-16

Open-label Study of Surufatinib in Japanese Patients

Phase 1/2 Completed

36 enrolled

Neuroendocrine Tumors

NCT04702737 2025-09-12

DeLLpro-300

Phase 1 Completed

41 enrolled 19 charts

EndocrineGenitourinary

Neuroendocrine Prostate Cancer

NCT04462471 2025-09-08

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

Phase 1 Completed

8 enrolled 8 charts

Thyroid cancer, follicular, Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT05017662 2025-09-04

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

20 enrolled

Neuroendocrine Tumors

NCT02820857 2025-09-03

BEVANEC

153 enrolled

Carcinoma, Neuroendocrine

NCT06439745 2025-09-02

cN0PTC

314 enrolled